Drawing investor attention can pose a challenge, even for companies with groundbreaking, new science. In a space teeming with competition, it’s vital that emerging biophama companies developing innovative therapies also establish strong messaging to reach and intrigue potential investors.
Posts by Stephanie Carrington
Stephanie Carrington is a Managing Director on Westwicke's life sciences team. She has extensive experience in healthcare investor relations and strategic communications. She has a BA in economics and international relations from Smith College and an MBA in finance and international business from New York University’s Stern School of Business.
Preparing for an IPO?
Download our latest eBook, Guide to Selecting a Winning IPO Team, to learn how to identify the right individuals and institutions to work with as you approach your IPO.